Skip to main content

Table 3 Lipid testing in the past 5 years for adults with low cardiovascular disease (CVD) risk (<10 %) by number of CVD risk factors

From: Relationship between cardiovascular risk and lipid testing in one health care system: a retrospective cohort study

Row(%) No risk factors 1-4 risk factors
  Lipid tests Lipid tests
a) Men
Age 0 1 2 3+ Total 0 1 2 3+ Total
25-34 64.2 27.4 6.4 2.0 891 60.3 26.3 8.5 4.9 763
35-44 41.6 40.2 11.6 6.6 2040 45.3 35.2 11.7 7.9 1438
45-54 29.3 43.3 18.0 9.4 1853 31.3 39.9 15.5 13.4 479
55-64 25.5 40.1 23.4 10.9 192 0.0 50.0 25.0 25.0 4
65-79 0.0 0.0 100.0 0.0 1      0
Total 40.4 39.0 13.5 7.0 4977 47.0 33.5 11.5 8.0 2684
b) Women
Age 0 1 2 3+ Total 0 1 2 3+ Total
25-34 74.8 19.6 3.4 2.2 2017 62.3 25.5 7.2 5.0 1242
35-44 50.6 35.0 10.1 4.3 3730 42.1 35.4 13.6 8.9 2706
45-54 29.9 43.4 18.4 8.3 4708 28.1 38.1 20.7 13.1 3285
55-64 22.4 40.4 22.1 15.2 3869 22.5 34.8 25.3 17.5 1616
65-79 20.4 37.2 24.4 18.0 861 18.4 26.6 32.3 22.8 158
Total 38.5 37.1 15.6 8.8 15,185 35.9 34.8 17.7 11.7 9007
  1. Risk factors include diabetes, treated hypertension, current smoker, body mass index >30. Yellow shading indicates more testing than recommended by the United States Preventive Services Task Force (USPSTF) for persons with no risk factors. Green shading indicates less testing than recommended for persons with one or more risk factors and who are not already on statins. Cross-hatch lines signify risk categories with no study subjects